Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 160 mg/12.5 mg tablets, USP 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2316-19.

D-0982-2018

July 16, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80538
Status
Ongoing
Classification
Class II
Quantity
195,234 bottles
Official record key
drug-enforcement:D-0982-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot Numbers: 1191160M, 1191161M, 1191162A, 1219363M, 1219364M, 1219365A, 1225613A, 1233944M, 1233945M, 1253253M, 1253254M

Distribution pattern: Product was distributed throughout the United States, including Hawaii and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations